464 related articles for article (PubMed ID: 29510390)
1. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Demetrovics Z; Coetzee C; Luderer M; Schellekens A; ; Matthys F
Eur Addict Res; 2018; 24(1):43-51. PubMed ID: 29510390
[TBL] [Abstract][Full Text] [Related]
2. [Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder].
Kapitány-Fövény M; Barta C; Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Coetzee C; Luderer M; Schellekens A; Matthys F; Demetrovics Z;
Psychiatr Hung; 2020; 35(4):435-447. PubMed ID: 33263293
[TBL] [Abstract][Full Text] [Related]
3. [International consensus for the screening, diagnosis and treatment of adult patients with substance use disorder and ADHD].
Crunelle CL; van den Brink W; Schellekens A; van de Glind G; Icasa Consortium B; Matthys F
Tijdschr Psychiatr; 2019; 61(7):477-487. PubMed ID: 31372969
[TBL] [Abstract][Full Text] [Related]
4. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
[TBL] [Abstract][Full Text] [Related]
5. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
[TBL] [Abstract][Full Text] [Related]
6. [Adolescents with concurrent ADHD and substance use disorder; international consensus].
Spijkerman R; Crunelle CL; Özgen MH; Begeman AHA; Dom G; van de Glind G; Groenman AP; van Kernebeek MW; Matthys F; Post M; Schellekens A; Staal W; van den Brink W; Hendriks VM
Tijdschr Psychiatr; 2021; 63(12):868-874. PubMed ID: 34978058
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
Simon N; Rolland B; Karila L
Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
[TBL] [Abstract][Full Text] [Related]
8. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.
Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
Eur Addict Res; 2020; 26(4-5):173-178. PubMed ID: 32599579
[TBL] [Abstract][Full Text] [Related]
9. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
Schubiner H
CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
[TBL] [Abstract][Full Text] [Related]
10. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
Upadhyaya HP
J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
[TBL] [Abstract][Full Text] [Related]
11. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
Kollins SH
Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications.
van der Burg D; Crunelle CL; Matthys F; van den Brink W
Curr Opin Psychiatry; 2019 Jul; 32(4):300-306. PubMed ID: 31008730
[TBL] [Abstract][Full Text] [Related]
13. [ADHD in adult patients with substance use disorders].
Luderer M; Kiefer F; Reif A; Moggi F
Nervenarzt; 2019 Sep; 90(9):926-931. PubMed ID: 31407043
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.
Pérez de los Cobos J; Siñol N; Pérez V; Trujols J
Br J Clin Pharmacol; 2014 Feb; 77(2):337-56. PubMed ID: 23216449
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
Ramos-Quiroga JA; Chalita PJ; Vidal R; Bosch R; Palomar G; Prats L; Casas M
Rev Neurol; 2012 Feb; 54 Suppl 1():S105-15. PubMed ID: 22374761
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for co-occurring ADHD and substance use disorders.
Mariani JJ; Levin FR
Am J Addict; 2007; 16 Suppl 1(Suppl 1):45-54; quiz 55-6. PubMed ID: 17453606
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
[TBL] [Abstract][Full Text] [Related]
18. [Summary of the practice guideline for the diagnosis and treatment of ADHD in adolescents and adults with addictions].
Matthys F; Joostens P; van den Brink W; Sabbe B
Ned Tijdschr Geneeskd; 2013; 157(24):A6025. PubMed ID: 23759179
[TBL] [Abstract][Full Text] [Related]
19. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.
van de Glind G; Konstenius M; Koeter MWJ; van Emmerik-van Oortmerssen K; Carpentier PJ; Kaye S; Degenhardt L; Skutle A; Franck J; Bu ET; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitány-Fövény M; Fatséas M; Auriacombe M; Schillinger A; Møller M; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Schoevers RA; Wallhed S; Barta C; Alleman P; ; Levin FR; van den Brink W
Drug Alcohol Depend; 2014 Jan; 134():158-166. PubMed ID: 24156882
[TBL] [Abstract][Full Text] [Related]
20. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations.
Klassen LJ; Bilkey TS; Katzman MA; Chokka P
Curr Drug Abuse Rev; 2012 Sep; 5(3):190-8. PubMed ID: 22571450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
